Effectiveness of a Community-based Intervention Programme to Promote Well-being in Older Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorNational Healthcare Group Polyclinics
About this trial
This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression.
Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. As part of the focal talks, the Public Health Questionnaire-9 (PHQ-9) will be conducted. Attendees with a PHQ-9 score of 1-9 will be invited to take part in the study. Up to 300 participants will be recruited and randomised into 2 arms: control arm (150 participants) and intervention arm (150 participants).
Participants in the intervention arm will undergo 8-week community intervention programme which includes 4 sessions on well-being and continuous follow-up with a Health Companion. Participants in the control arm will be offered to join a programme conducted by the SSAs 8 weeks after recruitment into the study. The programmes offered to the control group are independent of the study.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 55 and above
Score of 1-9 on the PHQ-9 questionnaire
Able to speak and understand English, Chinese or Malay
Able to provide informed consent
Disqualifiers
PHQ-9 score of 0
PHQ-9 score of 10 or more
Actively being followed up by a mental health professional
On psychotropic medication or are undergoing psychotherapy
Trial design
Design model
Parallel
Treatments tested in this trial
Community-based Intervention
BehavioralPsychoeducation Programme
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: ControlNo intervention 0 interventions
Group B: InterventionOther 1 intervention
Trial outcomes
Primary outcomes
1
Well-being
Measured by Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Minimum score: 7 Maximum score: 35 Higher scores indicate higher positive mental well-being (Better outcome).
Time frame
8 weeksSecondary outcomes
1
Depressive symptoms
Measured by Patient Health Questionnaire-9 (PHQ-9) Minimum score: 0 Maximum score: 27 Higher scores represent higher severity of the symptoms of depression (worse outcome). Specifically, scores of 0-4 represent none to minimal depression severity; scores of 5-9 represent mild depression severity; scores of 10-14 represent moderate depression; scores of 15-19 represent moderately severe depression; scores of 20-27 represent severe depression.
Time frame
8 weeks2
Anxiety symptoms
Measured by Generalised Anxiety Disorder-7 (GAD-7) Minimum score: 0 Maximum score: 21 Higher scores represent higher severity of anxiety symptoms (worse outcome). Specifically, scores of 0-4 represent minimal anxiety; scores of 5-9 represent mild anxiety; scores of 10-14 represent moderate anxiety; scores of 15-21 represent severe anxiety.
Time frame
8 weeks3
Loneliness
Measured by De Jong Gierveld Loneliness Scale Minimum score: 0 Maximum score: 6 Higher scores represent higher severity of loneliness (worse outcome). Specifically, scores of 0-2 represent low levels of loneliness; scores of 3-4 represent moderate levels of loneliness; scores of 5-6 represent intense/severe levels of loneliness.
Time frame
8 weeksOther outcomes
1
Acceptability, feasibility and satisfaction of the intervention
Measured through qualitative interviews, where qualitative data will be analysed qualitatively to understand participants' acceptability and satisfaction to the intervention programme, and the feasibility of the intervention programme.
Time frame
8 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
National Healthcare Group Polyclinics
Lead sponsor
Lien Foundation
Collaborator
Institute of Mental Health, Singapore
Collaborator
Nanyang Technological University
Collaborator
Fei Yue Community Services
Collaborator
Club HEAL
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: